Implementation Guidelines - Federal Transit Administration - U.S. ...

More documents

Recommendations

Info

DrugProof, Divison of Dynacare 543 South Hull St. Montgomery, AL 36103 888-777- 9497 / 334-241-0522 (Formerly: Alabama Reference Laboratories, Inc.) DrugProof, Division of Dynacare/Laboratory of Pathology, LLC 1229 Madison St., Suite 500, Nordstrom Medical Tower Seattle, WA 98104 206-386-2672 / 800-898-0180 (Formerly: Laboratory of Pathology of Seattle, Inc., DrugProof, Division of Laboratory of Pathology of Seattle, Inc.) DrugScan, Inc. P.O. Box 2969 1119 Mearns Rd. Warminster, PA 18974 215-674-9310 Dynacare Kasper Medical Laboratories * 14940-123 Ave. Edmonton, Alberta Canada T5V 1B4 780-451-3702 / 800-661-9876 ElSohly Laboratories, Inc. 5 Industrial Park Dr. Oxford, MS 38655 662-236-2609 Express Analytical Labs 1301 18th Ave NW, Suite 110 Austin, MN 55912 507-437-7322 Gamma-Dynacare Medical Laboratories* A Division of the Gamma-Dynacare Laboratory Partnership 245 Pall Mall St. London, ONT Canada N6A 1P4 519-679-1630 General Medical Laboratories 36 South Brooks St. Madison, WI 53715 608-267-6267 Kroll Laboratory Specialists, Inc. 1111 Newton St. Gretna, LA 70053 504-361-8989 / 800-433-3823 (Formerly: Laboratory Specialists, Inc.) LabOne, Inc. 10101 Renner Blvd. Lenexa, KS 66219 913-888-3927 / 800-728-4064 (Formerly: Center for Laboratory Services, a Division of LabOne, Inc.) Laboratory Corporation of America Holdings 7207 N. Gessner Road Houston, TX 77040 713-856-8288 / 800-800-2387 Laboratory Corporation of America Holdings 69 First Ave. Raritan, NJ 08869 908-526-2400 / 800-437-4986 (Formerly: Roche Biomedical Laboratories, Inc.) Appendix D. Certified Laboratories D-3 August 2002
Laboratory Corporation of America Holdings 1904 Alexander Drive Research Triangle Park, NC 27709 919-572-6900 / 800-833-3984 (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings 10788 Roselle Street San Diego, CA 92121 800-882-7272 (Formerly: Poisonlab, Inc.) Laboratory Corporation of America Holdings 1120 Stateline Road West Southaven, MS 38671 866-827-8042 / 800-233-6339 (Formerly: LabCorp Occupational Testing Services, Inc., MedExpress/National Laboratory Center) Marshfield Laboratories Forensic Toxicology Laboratory 1000 North Oak Ave. Marshfield, WI 54449 715-389-3734 / 800-331-3734 MAXXAM Analytics Inc.* 5540 McAdam Rd. Mississauga, ON Canada L4Z 1P1 905-890-2555 (Formerly: NOVAMANN (Ontario) Inc.) Medical College Hospitals Toxicology Laboratory, Department of Pathology 3000 Arlington Ave. Toledo, OH 43699 419-383-5213 MedTox Laboratories, Inc. 402 W. County Rd. D St. Paul, MN 55112 651-636-7466 / 800-832-3244 MetroLab-Legacy Laboratory Services 1225 NE 2nd Ave. Portland, OR 97232 503-413-5295 / 800-950-5295 Minneapolis Veterans Affairs Medical Center Forensic Toxicology Laboratory 1 Veterans Drive Minneapolis, Minnesota 55417 612-725-2088 National Toxicology Laboratories, Inc. 1100 California Ave. Bakersfield, CA 93304 661-322-4250 / 800-350-3515 Northwest Drug Testing, a division of NWT Inc. 1141 E. 3900 South Salt Lake City, UT 84124 801-293-2300 / 800-322-3361 (Formerly: NWT Drug Testing, NorthWest Toxicology, Inc.) Appendix D. Certified Laboratories D-4 August 2002
Page 1 and 2:
October 2009 Implementation Guideli
Page 3 and 4:
Notice This document is disseminate
Page 5 and 6:
METRIC/ENGLISH CONVERSION FACTORS E
Page 7 and 8:
Table of Contents Chapter 1. INTROD
Page 9 and 10:
Table of Contents (continued) Secti
Page 11 and 12:
Chapter 1. INTRODUCTION Section 1.
Page 13 and 14:
Transit employers may go beyond the
Page 15 and 16:
Recommendation: Know the Regulation
Page 17 and 18:
Sample Documentation Chapter 1. Int
Page 19 and 20:
DHHS-Certified Laboratories, Center
Page 21 and 22:
FTA Drug and Alcohol Management Inf
Page 23 and 24:
Research And Special Programs Admin
Page 25 and 26:
employment in safety-sensitive posi
Page 27 and 28:
What happens in these cases? The pu
Page 29 and 30:
Section 3. SAFETY-SENSITIVE • Ope
Page 31 and 32:
performing the volunteer service ar
Page 33 and 34:
Safety-sensitive Examples of Nation
Page 35 and 36:
• A description of the consequenc
Page 37 and 38:
projects, the employer should notif
Page 39 and 40:
Sample Documentation Chapter 2. Reg
Page 41 and 42:
Certification of Compliance for FTA
Page 43 and 44:
4. Atlanta Federal Center Suite 17T
Page 45 and 46:
1. Liability of Service Agents Yasu
Page 47 and 48:
plaintiffs agreed that their positi
Page 49 and 50:
FTA and FMCSA Regulatory Comparison
Page 51 and 52:
FTA and FMCSA Regulatory Comparison
Page 53 and 54:
process ensures that all critical c
Page 55 and 56:
Chapter 3. Program Formulation 3-4
Page 57 and 58:
Chapter 4. POLICY DEVELOPMENT AND C
Page 59 and 60:
concentration of 0.04 or greater th
Page 61 and 62:
has a confirmed alcohol concentrati
Page 63 and 64:
MRO before the employer is notified
Page 65 and 66:
policy with the requirement to form
Page 67 and 68:
Do not assume that your contractors
Page 69 and 70:
PRE-EMPLOYMENT DRUG TESTING NOTIFIC
Page 71 and 72:
Sample Program Notification Letter
Page 73 and 74:
authorized by the employer to make
Page 75 and 76:
The 60 minutes of awareness trainin
Page 77 and 78:
medications which could result in p
Page 79 and 80:
employees who have problems with pr
Page 81 and 82:
particular alcohol testing device t
Page 83 and 84:
emain current with the regulations
Page 85 and 86:
− Changes in Rules, Guidance and
Page 87 and 88:
Exhibit 5-1 Summary of Education an
Page 89 and 90:
Exhibit 5-3 Typical Agenda for Supe
Page 91 and 92:
Exhibit 5-4 REASONABLE SUSPICION TR
Page 93 and 94:
Chapter 6. TYPES OF TESTING Six typ
Page 95 and 96:
Previous DOT Employer Record Check
Page 97 and 98:
the “insufficient volume” proce
Page 99 and 100:
for employees what is meant by on-d
Page 101 and 102:
Nonfatal accidents involving a bus,
Page 103 and 104:
Testing for drugs and alcohol follo
Page 105 and 106:
iases in the process. To be conside
Page 107 and 108:
1. Determine how frequently random
Page 109 and 110:
In many small transit systems, ever
Page 111 and 112:
Before making the return-to-duty re
Page 113 and 114:
up testing program. The SAP must do
Page 115 and 116:
Employee Discharged BAC >= 0.04 Con
Page 117 and 118:
Employee Discharged Split Specimen
Page 119 and 120:
Sample Documentation Chapter 6. Typ
Page 121 and 122:
1) Accident Report Number: 2) Locat
Page 123 and 124:
Chapter 7. DRUG TESTING PROCEDURES
Page 125 and 126:
Recommendation Multiple Collection
Page 127 and 128:
spouse, relative) or a close person
Page 129 and 130:
The DOT requires the new version of
Page 131 and 132:
9. The collector must direct the em
Page 133 and 134:
evening contact telephone numbers i
Page 135 and 136:
temperature range (90.0 to 100.0 F)
Page 137 and 138:
publishes its final rule establishi
Page 139 and 140:
for the preceding 6 months ending o
Page 141 and 142:
Chapter 7. Drug Testing Procedures
Page 143 and 144:
• The MRO will verify the test re
Page 145 and 146:
The MRO may change a verified test
Page 147 and 148:
direct the DER to have the employee
Page 149 and 150:
employee for a retest under direct
Page 151 and 152:
Sample Documentation Chapter 7. Dru
Page 153 and 154:
Collection Site Checklist (cont.) (
Page 155 and 156:
12. You may now wash your hands and
Page 162 and 163:
Privacy Act Statement: (For Federal
Page 164 and 165:
than an EBT, that is approved by th
Page 166 and 167:
Breath Alcohol Technician (§40.213
Page 168 and 169:
availability and the need for backu
Page 170 and 171:
At the conclusion of the screen tes
Page 172 and 173:
sufficient amount of breath. A medi
Page 174 and 175:
In addition to stipulating the cons
Page 176 and 177:
Sample Documentation Chapter 8. Alc
Page 178 and 179:
[Federal Register: May 4, 2001 (Vol
Page 180 and 181:
The Conforming Products List is the
Page 182 and 183:
Highway Safety Programs; Model Spec
Page 184 and 185:
45420 Federal Register / Vol. 65, N
Page 186 and 187:
Page 188:
U.S. Department of Transportation (
Page 194 and 195:
Section 1. SAP QUALIFICATIONS A sub
Page 196 and 197:
Education/Treatment Program Referra
Page 198 and 199:
Employers are not required to follo
Page 200 and 201:
SAP, many employers have looked to
Page 202 and 203:
10 weeks, with most sessions schedu
Page 204 and 205:
_____________________________ _____
Page 206 and 207:
FOLLOW-UP TESTING PROCESS SAP Input
Page 208 and 209:
Alcohol Test Results
Page 210 and 211:
when the applicant was assigned saf
Page 212 and 213:
may arrange to have the consortium
Page 214 and 215:
• Employers and service agents sh
Page 216 and 217:
The list of randomly selected trans
Page 218 and 219:
A. At a Nonprofit Agency or Indepen
Page 220 and 221:
Reporting Period: Laboratory Name a
Page 222 and 223:
Record Retention Checklists (page 2
Page 224 and 225:
Retains CCF1 Split Lab - CCF1 Labor
Page 226 and 227:
CCF1 Split Lab Retains - CCF1 Labor
Page 228 and 229:
U.S. DEPARTMENT OF TRANSPORTATION D
Page 230 and 231:
Chapter 11. CONSORTIA AND THIRD PAR
Page 232 and 233:
Greater Expertise. The FTA and DOT
Page 234 and 235:
Section 2. CONSIDERATIONS IN ESTABL
Page 236 and 237:
esults (≥0.02) between the BAT an
Page 238 and 239:
consideration. Thus, the more diver
Page 240 and 241:
Section 5. IS A CONSORTIUM RIGHT FO
Page 242 and 243:
• Procurement of testing services
Page 244 and 245:
• Consider which consortium model
Page 246 and 247:
Exhibit 11-1 Role of State DOTs in
Page 248 and 249:
Exhibit 11-3 CONSORTIA RESPONSIBILI
Page 250 and 251:
Chapter 12. PROGRAM MONITORING As a
Page 252 and 253: • Conduct periodic review of serv
Page 254 and 255: compliance. You are encouraged to c
Page 256 and 257: Chapter 13. THE DRUG-FREE WORKPLACE
Page 258 and 259: Violations of the act may result in
Page 260 and 261: Exhibit 13-1 DRUG-FREE WORKPLACE AC
Page 262 and 263: Chapter 14. SUBSTANCE ABUSE MANAGEM
Page 264 and 265: Notification of audit Requested mat
Page 266 and 267: them to move throughout the facilit
Page 268 and 269: above materials. ⎯⎯Procedures t
Page 270 and 271: DAY 3 Time Activity Team Address of
Page 272 and 273: Date of Collection Jan-01 Nov-00 Se
Page 274 and 275: Time of the Test Time of the Test 8
Page 276 and 277: Each auditor will discuss the porti
Page 278 and 279: Sample Re-audit Agenda DAY 1 Time A
Page 280 and 281: Index of Appendices Appendix A. Acr
Page 282 and 283: AA Alcoholics Anonymous Appendix A.
Page 284 and 285: RFP Request for Proposal RIA Radio
Page 286 and 287: Newsletters Appendix B. Additional
Page 288 and 289: U.S. Department of Labor. What Work
Page 290 and 291: Other Government Web sites Drug and
Page 292 and 293: Appendix C Americans with Disabilit
Page 294 and 295: sensitive duties for the illegal us
Page 296 and 297: If the individual is qualified and
Page 298 and 299: allegation of discrimination under
Page 300 and 301: Appendix D. Certified Laboratories
Page 304 and 305: One Source Toxicology Laboratory, I
Page 306 and 307: The following laboratories are volu
Page 308 and 309: Federal Register / Vol. 65, No. 141
Page 314 and 315: Appendix F. Fact Sheets Drug Detect
Page 316 and 317: Social Issues • Two-thirds of all
Page 318 and 319: • The euphoric stimulation increa
Page 320 and 321: • Paranoia • Profuse sweating a
Page 322 and 323: connection between marijuana smokin
Page 324 and 325: Opiates (Narcotics) Fact Sheet Opia
Page 326 and 327: Phencyclidine (PCP) Fact Sheet Phen
Page 328 and 329: Appendix G Questions and Answers
Page 330 and 331: ecipient, and someone other than th
Page 332 and 333: Q. Can transit operators receive wa
Page 334 and 335: Q. If an employee changed jobs prio
Page 336 and 337: Q. How much training are employers
Page 338 and 339: acceptable for the company-required
Page 340 and 341: Q. In a post-accident situation req
Page 342 and 343: employees and 50 non-DOT employees,
Page 344 and 345: Q: What actual address is required
Page 346 and 347: Q: Can a split specimen be sent to
Page 348 and 349: actual employee of the employer may
Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
Page 352 and 353:
an observer, or a monitor for co-wo
Page 354 and 355:
Q: If a collector makes an error on
Page 356 and 357:
Appendix H Terms and Definitions
Page 358 and 359:
indirectly, one controls or has the
Page 360 and 361:
Confirmation validity test Confirme
Page 362 and 363:
These terms include any designee of
Page 364 and 365:
Medical Review Officer (MRO) A pers
Page 366 and 367:
Random test Reason to believe Reaso
Page 368 and 369:
Safety-sensitive function Any of th
Page 370 and 371:
trolley bus, or vessel. A “mass t
Page 373 and 374:
49 CFR Part 40 Updated August 31, 2
Page 375 and 376:
§ 40.89 What is validity testing,
Page 377 and 378:
Page 4 of 100 § 40.287 What inform
Page 379 and 380:
Page 6 of 100 Subpart A - Administr
Page 381 and 382:
Page 8 of 100 Medical Review Office
Page 383 and 384:
Page 10 of 100 § 40.17 Is an emplo
Page 385 and 386:
Page 12 of 100 (b) You must request
Page 387 and 388:
Page 14 of 100 (4) The collector's
Page 389 and 390:
Page 16 of 100 (1) To avoid distrac
Page 391 and 392:
Page 18 of 100 (f) Direct the emplo
Page 393 and 394:
Page 20 of 100 (g) As the collector
Page 395 and 396:
Page 22 of 100 participate in the D
Page 397 and 398:
Page 24 of 100 (b) You must determi
Page 399 and 400:
Page 26 of 100 (d) If you have not
Page 401 and 402:
Page 28 of 100 December 31 of the p
Page 403 and 404:
Page 30 of 100 (a) Review Copy 2 of
Page 405 and 406:
Page 32 of 100 (1) As the DER, you
Page 407 and 408:
Page 34 of 100 (i) Recent needle tr
Page 409 and 410:
Page 36 of 100 (2) If you receive i
Page 411 and 412:
Page 38 of 100 (iii) If a negative
Page 413 and 414:
Page 40 of 100 (6) Result of the te
Page 415 and 416:
Page 42 of 100 (d) When you receive
Page 417 and 418:
Page 44 of 100 (1) Report that the
Page 419 and 420:
Page 46 of 100 (2) There is not an
Page 421 and 422:
Page 48 of 100 (c) The laboratory r
Page 423 and 424:
Page 50 of 100 (6) The failure to d
Page 425 and 426:
Page 52 of 100 partially meets thes
Page 427 and 428:
Page 54 of 100 (c) As the user of t
Page 429 and 430:
Page 56 of 100 (vi) You must then d
Page 431 and 432:
Page 58 of 100 (i) You may transmit
Page 433 and 434:
Page 60 of 100 (b) In the case of a
Page 435 and 436:
Page 62 of 100 (iii) Key DOT drug t
Page 437 and 438:
Page 64 of 100 § 40.295 May employ
Page 439 and 440:
Page 66 of 100 (e) The requirements
Page 441 and 442:
Page 68 of 100 accident drug test r
Page 443 and 444:
Page 70 of 100 § 40.343 What tasks
Page 445 and 446:
Page 72 of 100 and follow-up testin
Page 447 and 448:
Page 74 of 100 (b) In exercising th
Page 449 and 450:
Page 76 of 100 resubmit the matter
Page 451 and 452:
Page 78 of 100 § 40.397 When does
Page 453 and 454:
Appendix A to Part 40 - DOT Standar
Page 455 and 456:
Appendix C to Part 40-DOT Drug Test
Page 457 and 458:
Page 84 of 100 Appendix E to Part 4
Page 459 and 460:
Appendix G to Part 40—Alcohol Tes
Page 461 and 462:
Page 88 of 100
Page 463 and 464:
Page 90 of 100
Page 465 and 466:
I. Employer: Company Name: Page 92
Page 467 and 468:
Page 94 of 100 The following form a
Page 469 and 470:
Section III. Drug Testing Data Page
Page 471 and 472:
Page 98 of 100 TIP ~ Even though so
Page 473 and 474:
Page 100 of 100 Finally, additional
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Federal Register / Vol. 68, No. 250
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
49 CFR Part 655
Page 509 and 510:
2 Electronic access to this rule an
Page 511 and 512:
duty and follow-up testing under sp
Page 513 and 514:
When the drug and alcohol rules ini
Page 515 and 516:
the consequences for prohibited dru
Page 517 and 518:
Labor unions: 3 Trade associations:
Page 519 and 520:
FTA Response. FTA opts not to inclu
Page 521 and 522:
Since each employer uses its own te
Page 523 and 524:
Most of the commenters to this sect
Page 525 and 526:
themselves that employees can succe
Page 527 and 528:
Several commenters responding to th
Page 529 and 530:
service providers and the employer.
Page 531 and 532:
esponsibility of FTA transit funds
Page 533 and 534:
26 Federalism assessment. However,
Page 535 and 536:
Part 655 - Prevention of Alcohol Mi
Page 537 and 538:
655.52 Substance abuse professional
Page 539 and 540:
(b) This part must be read in conju
Page 541 and 542:
(2) The volunteer performs a safety
Page 543 and 544:
Refuse to submit means any circumst
Page 545 and 546:
An employer must have an anti-drug
Page 547 and 548:
part. (c) Specific information conc
Page 549 and 550:
(5) Phencyclidine. (c) Consumption
Page 551 and 552:
concentration less than 0.04. This
Page 553 and 554:
§655.43 Reasonable suspicion testi
Page 555 and 556:
48 the reasons the alcohol test was
Page 557 and 558:
(c) Rates for drug testing. (1) Whe
Page 559 and 560:
annual percentage rate under this p
Page 561 and 562:
(a) Each employer shall require a c
Page 563 and 564:
56 for evaluating and resolving pro
Page 565 and 566:
qualifying the supervisors to make
Page 567 and 568:
60 (12) Number of covered employees
Page 569 and 570:
post-accident alcohol test indicati
Page 571 and 572:
equired to be maintained by this pa
Page 573 and 574:
(b) A certification must be authori
Page 575:
Drug-Free Workplace Act
Page 591 and 592:
TABLE OF CONTENTS INTRODUCTION ....
Page 593 and 594:
egulations that have been made sinc
Page 595 and 596:
The behaviors that are prohibited b
Page 597 and 598:
⎯ An individual who refuses to su
Page 599 and 600:
Have employees been notified that p
Page 601 and 602:
⎯ Add a bluing agent to the toile
Page 603 and 604:
Are employees who are subject to te
Page 605 and 606:
LABORATORY TESTING Are all drug tes
Page 607 and 608:
⎯ Direct the analysis of the spli
Page 609 and 610:
Is only one test conducted at a tim
Page 611 and 612:
Does the BAT notify the employer’
Page 613 and 614:
Does the SAP evaluate whether a saf
Page 615 and 616:
ADMINISTRATIVE REQUIREMENTS If a pr
Page 617 and 618:
Are procedures in place to have emp
Page 619 and 620:
hours following the accident, the e
Page 621 and 622:
Are random numbers substituted only
Page 623 and 624:
Are employees that are subject to f
Page 625 and 626:
OTHER TRAINING Consistent with the
Page 627 and 628:
♦ Documents presented by a covere
Page 629 and 630:
CERTIFICATION ♦ Each year transit
Page 631 and 632:
A R DMINISTRATIVE EQUIREMENTS Do th
Page 633 and 634:
DRUG AND ALCOHOL POLICY REVIEW QUES
Page 635 and 636:
Meeting FTA thresholds; Meeting dru
Page 637 and 638:
CONSEQUENCES OF A FAILED OR REFUSED
Page 639 and 640:
How much notice is given to the emp
Page 641 and 642:
RECORDS MANAGEMENT QUESTIONNAIRE AP
Page 643 and 644:
If the information requested is not
Page 645 and 646:
Has the employer met the minimum an
Page 647 and 648:
Do the records indicate that any dr
Page 649 and 650:
Does the employer utilize the stand
Page 651 and 652:
If tests are cancelled because of a
Page 653 and 654:
If you conducted the initial test,
Page 655 and 656:
SALIVA TEST TECHNICIAN QUESTIONNAIR
Page 657 and 658:
MEDICAL REVIEW OFFICER (MRO) QUESTI
Page 659 and 660:
What action would you take if the s
Page 661 and 662:
• • • As the SAP, can you sub
Page 663:
Do you assist your members in any w
show all

Implementation Guidelines - Federal Transit Administration - U.S. ...

Create successful ePaper yourself

Delete template?

Save as template?